SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-24-002961
Filing Date
2024-02-02
Accepted
2024-02-02 16:38:02
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM S-3 rvph20240130_s3.htm S-3 391099
2 EXHIBIT 4.5 ex_621120.htm EX-4.5 409430
3 EXHIBIT 4.6 ex_621121.htm EX-4.6 448147
4 EXHIBIT 5.1 ex_621122.htm EX-5.1 25433
5 EXHIBIT 23.1 ex_621123.htm EX-23.1 3726
6 EXHIBIT FILING FEES ex_621124.htm EX-FILING FEES 43445
7 ex_621122img003.jpg GRAPHIC 4163
8 ex_621122img004.jpg GRAPHIC 4996
9 ex_621122img005.jpg GRAPHIC 3864
10 ex_621122img006.jpg GRAPHIC 3864
11 ex_621122img007.jpg GRAPHIC 3864
12 rvph20240130_s3img001.jpg GRAPHIC 4143
13 rvph20240130_s3img002.jpg GRAPHIC 4143
  Complete submission text file 0001437749-24-002961.txt   1363365
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276848 | Film No.: 24592160
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)